AZ and Novoheart collaborate on 'heart in a jar', to develop...

Stem cell biotech Novoheart is to collaborate with AstraZeneca to develop a “heart in a jar” that will be used to help develop new heart failure drugs.

FDA nod for AZ’s Calquence sets up new Imbruvica showdown

AstraZeneca, Merck cue up FDA verdict on selumetinib next ye...

AZ fleshes out positive trial of revitalised lupus drug anif...

AZ preps for US filing of kidney disease anaemia drug

AstraZeneca is gearing up for a US filing for its roxadustat, a potential drug for patients with anaemia from chronic kidney disease (CKD), after supportive phase 3 results.

AZ's trio of new China R&D initiatives includes $1bn fund

AstraZeneca has announced three research initiatives in China including a potential $1 billion investment fund, in a country described by CEO Pascal Soriot as a “scientific powerhouse”.